One-Time CRISPR Gene Editing Shows Lasting Cholesterol Reduction

Coverage, in order

1. 2d ago
   Inside Precision Medicine indie peer-reviewed

   One-Time CRISPR Gene Editing Shows Lasting Cholesterol Reduction

   A single dose of CRISPR base editing could provide years of cholesterol control, potentially reducing the need for lifelong medication in patients with severe lipid disorders. In a study published in Nature , researchers demonstrated sustained suppression of a cholesterol-regulating protein for up…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.